GRP
ZBIO

Global Retirement Partners’s Zenas BioPharma ZBIO Stock Holding History

Global Retirement Partners’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Buy
+420
New +$8.35K ﹤0.01% 3357
2025
Q4 		$399 Sell
11
-4
-27% -$132 ﹤0.01% 4036
2025
Q3 		$333 Buy
+15
New +$244 ﹤0.01% 3693

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Global Retirement Partners's ZBIO Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Zenas BioPharma (ZBIO) in Q2 2026: 420 shares worth $10.7K. The stake represents ﹤0.01% of the portfolio and ranks #3357 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in ZBIO as recently as Q4 2025.

Global Retirement Partners first reported a position in ZBIO in Q3 2025 and has held it in 3 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Global Retirement Partners held 420 shares of Zenas BioPharma worth $10.7K as of Q2 2026.
  • Zenas BioPharma was a new Global Retirement Partners position in Q2 2026.
  • Zenas BioPharma made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3357 holding.
  • Global Retirement Partners first reported a position in Zenas BioPharma in Q3 2025 and has held it in 3 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.